Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease

Atherosclerosis

Volumn 228, Issue 2, 2013, Pages 346-352

  Jia, Lei ^a   Zhu, Ling ^b   Wang, Ji Zheng ^a   Wang, Xiao Jian ^a   Chen, Jing Zhou ^a   Song, Lei ^a   Wu, Yong Jian ^a   Sun, Kai ^a   Yuan, Zu Yi ^b   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Atherosclerosis; Coronary artery disease; DNA methylation; FOXP3; Regulatory T cells

Indexed keywords

DNA; DNA METHYLTRANSFERASE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMETHYLATION; DISEASE SEVERITY; DNA METHYLATION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN METHYLATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE;

ACUTE CORONARY SYNDROME; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; ENZYME INHIBITORS; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 84878109610     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.027     Document Type: Article

References (39)

1. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2008, 117:e25-146.
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Sakaguchi S. Naturally arising foxp3-expressing cd25+cd4+ regulatory t cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
4. George J. Mechanisms of disease: the evolving role of regulatory t cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 2008, 5:531-540.
5. Ait-Oufella H., Salomon B.L., Potteaux S., et al. Natural regulatory t cells control the development of atherosclerosis in mice. Nat Med 2006, 12:178-180.
6. Foks A.C., Frodermann V., ter Borg M., et al. Differential effects of regulatory t cells on the initiation and regression of atherosclerosis. Atherosclerosis 2011, 218:53-60.
7. Dietrich T., Hucko T., Schneemann C., et al. Local delivery of il-2 reduces atherosclerosis via expansion of regulatory t cells. Atherosclerosis 2012, 220:329-336.
8. Sasaki N., Yamashita T., Takeda M., et al. Oral anti-cd3 antibody treatment induces regulatory t cells and inhibits the development of atherosclerosis in mice. Circulation 2009, 120:1996-2005.
9. Feng J., Zhang Z., Kong W., Liu B., Xu Q., Wang X. Regulatory t cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoe-/- mice. Cardiovasc Res 2009, 84:155-163.
10. Mor A., Luboshits G., Planer D., Keren G., George J. Altered status of cd4(+)cd25(+) regulatory t cells in patients with acute coronary syndromes. Eur Heart J 2006, 27:2530-2537.
11. Cheng X., Yu X., Ding Y.J., et al. The th17/treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008, 127:89-97.
12. de Boer O.J., van der Meer J.J., Teeling P., van der Loos C.M., van der Wal A.C. Low numbers of foxp3 positive regulatory t cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007, 2:e779.
13. Ammirati E., Cianflone D., Banfi M., et al. Circulating cd4+cd25hicd127lo regulatory t-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:1832-1841.
14. Jones P.A., Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 2009, 10:805-811.
15. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999, 43:985-991.
16. Zawadzki C., Chatelain N., Delestre M., et al. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 2009, 204:e4-14.
17. Sharma P., Kumar J., Garg G., et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 2008, 27:357-365.
18. Stenvinkel P., Karimi M., Johansson S., et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J Intern Med 2007, 261:488-499.
19. Baron U., Floess S., Wieczorek G., et al. DNA demethylation in the human foxp3 locus discriminates regulatory t cells from activated foxp3(+) conventional t cells. Eur J Immunol 2007, 37:2378-2389.
20. Floess S., Freyer J., Siewert C., et al. Epigenetic control of the foxp3 locus in regulatory t cells. PLoS Biol 2007, 5:e38.
21. Huehn J., Polansky J.K., Hamann A. Epigenetic control of foxp3 expression: the key to a stable regulatory t-cell lineage?. Nat Rev Immunol 2009, 9:83-89.
22. Lal G., Zhang N., van der Touw W., et al. Epigenetic regulation of foxp3 expression in regulatory t cells by DNA methylation. J Immunol 2009, 182:259-273.
23. Stockis J., Fink W., Francois V., et al. Comparison of stable human treg and th clones by transcriptional profiling. Eur J Immunol 2009, 39:869-882.
24. Wieczorek G., Asemissen A., Model F., et al. Quantitative DNA methylation analysis of foxp3 as a new method for counting regulatory t cells in peripheral blood and solid tissue. Cancer Res 2009, 69:599-608.
25. de Vries I.J., Castelli C., Huygens C., et al. Frequency of circulating tregs with demethylated foxp3 intron 1 in melanoma patients receiving tumor vaccines and potentially treg-depleting agents. Clin Cancer Res 2011, 17:841-848.
26. Sullivan D.R., Marwick T.H., Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990, 119:1262-1267.
27. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M.G. Rapamycin promotes expansion of functional cd4+cd25+foxp3+ regulatory t cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006, 177:8338-8347.
28. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory t cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
29. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., et al. Instability of the transcription factor foxp3 leads to the generation of pathogenic memory t cells in vivo. Nat Immunol 2009, 10:1000-1007.
30. Merlo A., Tagliabue E., Menard S., Balsari A. Matured human monocyte-derived dendritic cells (modcs) induce expansion of cd4+cd25+foxp3+ t cells lacking regulatory properties. Immunol Lett 2008, 117:106-113.
31. Sakaguchi S. Naturally arising cd4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
32. Kim H.P., Leonard W.J. Creb/atf-dependent t cell receptor-induced foxp3 gene expression: a role for DNA methylation. J Exp Med 2007, 204:1543-1551.
33. Nagar M., Vernitsky H., Cohen Y., et al. Epigenetic inheritance of DNA methylation limits activation-induced expression of foxp3 in conventional human cd25-cd4+ t cells. Int Immunol 2008, 20:1041-1055.
34. Huang Y., Peng K., Su J., Xu Y., Wang S. Different effects of homocysteine and oxidized low density lipoprotein on methylation status in the promoter region of the estrogen receptor alpha gene. Acta Biochim Biophys Sin (Shanghai) 2007, 39:19-26.
35. Mor A., Luboshits G., Planer D., Keren G., George J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006, 27(21):2530-2537.
36. Mor A., Planer D., Luboshits G., et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27(4):893-900.
37. Wang J., Ren Z., Xu Y., Xiao S., Meydani S.N. Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. Am J Pathol 2012, 180(1):221-234.
38. Wong C.P., Nguyen L.P., Noh S.K., Bray T.M., Bruno R.S., Ho E. Induction of regulatory T cells by green tea polyphenol EGCG. Immunol Lett 2011, 139(1-2):7-13.
39. Polansky J.K., Kretschmer K., Freyer J., et al. DNA methylation controls foxp3 gene expression. Eur J Immunol 2008, 38:1654-1663.